Osmometric heart monitoring device and methods

• US 8,086,309 B2
• Filed: 04/26/2010
• Issued: 12/27/2011
• Est. Priority Date: 07/18/2007
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Shuros, Allan Charles, Mokelke, Eric A., Kane, Michael John, Qu, Jihong
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Kimball, Jeremiah
• Application Number:
  US12/767,604
• Publication Number:
  US 20100204744A1
• Time in Patent Office: 610 Days
• Field of Search: 607/22
• US Class Current: 607/22
• CPC Class Codes: A61B 2562/02 Details of sensors specially adapted for in-vivo measurements
• CPC Class Codes: A61B 5/0006 ECG or EEG signals
• CPC Class Codes: A61B 5/02028 Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
• CPC Class Codes: A61B 5/076 Permanent implantations telemetry using implanted circuitry A61B5/0031; implanted stimulators for therapy A61N1/3605, A61N1/362, A61N1/372
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/36557 controlled by chemical substances in blood
• CPC Class Codes: A61N 1/3702 Physiological parameters A61N1/365 takes precedence; evoked response A61N1/371
• CPC Class Codes: G01N 13/04 Investigating osmotic effects

Abstract

Embodiments of the invention are related to monitoring devices and methods with osmometric sensors, amongst other things. In an embodiment, an implantable heart failure monitoring system includes an implantable osmometric sensor configured to generate a signal corresponding to osmotic strength of a bodily fluid. The osmometric sensor includes a rigid wall member defining an enclosed volume resisting deformation, the rigid wall member comprising a semi-permeable membrane. The sensor also includes a signaling element comprising a first side, a second side, and a plurality of dimples configured to resist deformation until a threshold differential exists between the first and second sides. Other aspects and embodiments are provided herein.

Claims

1. An implantable heart failure monitoring system comprising:

an implantable osmometric sensor configured to generate a signal corresponding to osmotic strength of a bodily fluid, the osmometric sensor comprising

a rigid wall member defining an enclosed volume resisting deformation, the rigid wall member comprising a semi-permeable membrane;

a signaling element comprising

a transducing structure comprising;

a first side;

a second side; and

a plurality of dimples configured to resist deformation until a threshold differential exists between the first side and second side of the transducing structure.

2. The implantable heart failure monitoring system of claim 1, the implantable osmometric sensor further comprising a lead and a first conductor, wherein the first conductor passes through the lead and provide communication with the signaling element.

3. The implantable heart failure monitoring system of claim 1, wherein a pressure sensor is disposed remotely from the transducing structure.

4. The implantable heart failure monitoring system of claim 3, wherein the pressure sensor is configured to generate a wireless signal corresponding to pressure sensed by the pressure sensor.

5. The implantable heart failure monitoring system of claim 3, further comprising a controller in communication with the implantable osmometric sensor, the controller configured to receive and process the signal corresponding to osmotic strength of the bodily fluid.

6. The implantable heart failure monitoring system of claim 5, the controller further configured to generate electrical stimulation pulses to be delivered to a target tissue.

7. The implantable heart failure monitoring system of claim 5, the controller configured to generate a warning notification if the osmotic strength of the bodily fluid falls below a preselected threshold level.

8. The implantable heart failure monitoring system of claim 5, the controller configured to modulate a cardiac pacing rate based on the signal generated by the osmometric sensor.

9. The implantable heart failure monitoring system of claim 1, wherein each of the plurality of dimples is configured to invert at different threshold pressure differentials.

10. The implantable heart failure monitoring system of claim 1, further comprising a controller in communication with the implantable osmometric sensor, the controller configured to receive and process the signal corresponding to osmotic strength of the bodily fluid.

11. The implantable heart failure monitoring system of claim 1, the controller further configured to generate electrical stimulation pulses to be delivered to a target tissue.

12. The implantable heart failure monitoring system of claim 1, the controller configured to generate a warning notification if the osmotic strength of the bodily fluid falls below a preselected threshold level.

13. The implantable heart failure monitoring system of claim 1, the controller configured to modulate a cardiac pacing rate based on the signal generated by the osmometric sensor.

14. The implantable heart failure monitoring system of claim 1, wherein the transducing structure comprises a dome shape.

15. The implantable heart failure monitoring system of claim 9, wherein the dimples comprise a semi-rigid material.

16. The implantable heart failure monitoring system of claim 1, wherein the dimples comprise a material that changes resistance based on flexion.

17. The implantable heart failure monitoring system of claim 1, wherein the enclosed volume comprises a solvent and one or more solutes.

18. The implantable heart failure monitoring system of claim 17, wherein the solvent comprises water.

19. The implantable heart failure monitoring system of claim 17, wherein the solute comprises at least one of a protein, a carbohydrate, inorganic salts, organic salts, inorganic acids, inorganic bases, organic acids, organic bases, lipids, and amino acids.

20. The implantable heart failure monitoring system of claim 17, wherein the solution comprises a biocompatible chemical compound.